PMC:7079862 / 3398-5782 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"127","span":{"begin":788,"end":854},"obj":"Gene"},{"id":"128","span":{"begin":1666,"end":1670},"obj":"Gene"},{"id":"129","span":{"begin":2265,"end":2317},"obj":"Gene"},{"id":"130","span":{"begin":17,"end":25},"obj":"Species"},{"id":"131","span":{"begin":105,"end":115},"obj":"Species"},{"id":"132","span":{"begin":130,"end":135},"obj":"Species"},{"id":"133","span":{"begin":136,"end":149},"obj":"Species"},{"id":"134","span":{"begin":175,"end":202},"obj":"Species"},{"id":"135","span":{"begin":203,"end":224},"obj":"Species"},{"id":"136","span":{"begin":245,"end":255},"obj":"Species"},{"id":"137","span":{"begin":350,"end":360},"obj":"Species"},{"id":"138","span":{"begin":583,"end":593},"obj":"Species"},{"id":"139","span":{"begin":1129,"end":1139},"obj":"Species"},{"id":"140","span":{"begin":1252,"end":1262},"obj":"Species"},{"id":"141","span":{"begin":1401,"end":1411},"obj":"Species"},{"id":"142","span":{"begin":1575,"end":1585},"obj":"Species"},{"id":"143","span":{"begin":1764,"end":1774},"obj":"Species"},{"id":"144","span":{"begin":1860,"end":1868},"obj":"Species"},{"id":"145","span":{"begin":2091,"end":2101},"obj":"Species"},{"id":"146","span":{"begin":79,"end":88},"obj":"Species"},{"id":"147","span":{"begin":117,"end":128},"obj":"Species"},{"id":"148","span":{"begin":331,"end":340},"obj":"Species"},{"id":"149","span":{"begin":370,"end":381},"obj":"Species"},{"id":"150","span":{"begin":564,"end":573},"obj":"Species"},{"id":"151","span":{"begin":601,"end":612},"obj":"Species"},{"id":"152","span":{"begin":676,"end":687},"obj":"Species"},{"id":"153","span":{"begin":952,"end":961},"obj":"Species"},{"id":"154","span":{"begin":972,"end":981},"obj":"Species"},{"id":"155","span":{"begin":1111,"end":1120},"obj":"Species"},{"id":"156","span":{"begin":1272,"end":1283},"obj":"Species"},{"id":"157","span":{"begin":1419,"end":1430},"obj":"Species"},{"id":"158","span":{"begin":1743,"end":1752},"obj":"Species"},{"id":"159","span":{"begin":1775,"end":1786},"obj":"Species"},{"id":"160","span":{"begin":2072,"end":2081},"obj":"Species"},{"id":"161","span":{"begin":2102,"end":2113},"obj":"Species"},{"id":"162","span":{"begin":2184,"end":2195},"obj":"Species"},{"id":"163","span":{"begin":2323,"end":2334},"obj":"Species"}],"attributes":[{"id":"A128","pred":"tao:has_database_id","subj":"128","obj":"Gene:8732"},{"id":"A130","pred":"tao:has_database_id","subj":"130","obj":"Tax:9606"},{"id":"A131","pred":"tao:has_database_id","subj":"131","obj":"Tax:12059"},{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"Tax:9606"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"Tax:11118"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"Tax:12814"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"Tax:162145"},{"id":"A136","pred":"tao:has_database_id","subj":"136","obj":"Tax:10508"},{"id":"A137","pred":"tao:has_database_id","subj":"137","obj":"Tax:12059"},{"id":"A138","pred":"tao:has_database_id","subj":"138","obj":"Tax:12059"},{"id":"A139","pred":"tao:has_database_id","subj":"139","obj":"Tax:12059"},{"id":"A140","pred":"tao:has_database_id","subj":"140","obj":"Tax:12059"},{"id":"A141","pred":"tao:has_database_id","subj":"141","obj":"Tax:12059"},{"id":"A142","pred":"tao:has_database_id","subj":"142","obj":"Tax:12059"},{"id":"A143","pred":"tao:has_database_id","subj":"143","obj":"Tax:12059"},{"id":"A144","pred":"tao:has_database_id","subj":"144","obj":"Tax:9606"},{"id":"A145","pred":"tao:has_database_id","subj":"145","obj":"Tax:12059"},{"id":"A146","pred":"tao:has_database_id","subj":"146","obj":"Tax:11520"},{"id":"A147","pred":"tao:has_database_id","subj":"147","obj":"Tax:42789"},{"id":"A148","pred":"tao:has_database_id","subj":"148","obj":"Tax:11520"},{"id":"A149","pred":"tao:has_database_id","subj":"149","obj":"Tax:42789"},{"id":"A150","pred":"tao:has_database_id","subj":"150","obj":"Tax:11520"},{"id":"A151","pred":"tao:has_database_id","subj":"151","obj":"Tax:42789"},{"id":"A152","pred":"tao:has_database_id","subj":"152","obj":"Tax:12814"},{"id":"A153","pred":"tao:has_database_id","subj":"153","obj":"Tax:11520"},{"id":"A154","pred":"tao:has_database_id","subj":"154","obj":"Tax:11520"},{"id":"A155","pred":"tao:has_database_id","subj":"155","obj":"Tax:11520"},{"id":"A156","pred":"tao:has_database_id","subj":"156","obj":"Tax:42789"},{"id":"A157","pred":"tao:has_database_id","subj":"157","obj":"Tax:42789"},{"id":"A158","pred":"tao:has_database_id","subj":"158","obj":"Tax:11520"},{"id":"A159","pred":"tao:has_database_id","subj":"159","obj":"Tax:42789"},{"id":"A160","pred":"tao:has_database_id","subj":"160","obj":"Tax:11520"},{"id":"A161","pred":"tao:has_database_id","subj":"161","obj":"Tax:42789"},{"id":"A162","pred":"tao:has_database_id","subj":"162","obj":"Tax:12814"},{"id":"A163","pred":"tao:has_database_id","subj":"163","obj":"Tax:42789"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Study Population Patients (N) Samples Country Assays Overall prevalence or RVI Influenza Picornaviruses (rhinovirus, enterovirus) Human coronaviruses (229E, NL63, OC43, HKU1) Respiratory syncytial virus Human metapneumovirus Parainfluenza virus Adenovirus\nDaubin 2006 IMV for \u003e 48 h 187 TA France Viral culture, IFA, NAAT 32 (17%) Influenza A 7 (4%) Rhinovirus 19 (10%)\nEnterovirus 2 (1%) 1 (0.5%) 2 (1%) 0 (0%) 1 (0.5%) 1 (0.5%)\nCameron 2006 COPD exacerbation requiring NIV or IMV 105 PS Australia IFA, viral culture, NAAT, serology 46 (43%) Influenza A 14 (13%)\nInfluenza B 6 (6%) Rhinovirus 7 (7%)\nEnterovirus 2 (2%) 3 (3%) 7 (7%) 3 (3%) 11 (10%) 0 (0%)\nSchnell 2014 Acute respiratory failure 70, 47 (67%) mechanically ventilated PS, BAL France IFA, NAAT 34 (49%) Influenza A 11 (16%)\nInfluenza B 2 (3%) Rhinovirus 6 (9%) 5 (7%) 4 (6%) 4 (6%) 1 (1%) 3 (4%)\nLegoff 2005 Acute pneumonia admitted to ICU 41 BAL France Viral culture, IFA, NAAT 13 (32%) Influenza A 7 (17%)\nInfluenza B 1 (2%) 0 (0%) 0 (0%) 2 (5%) 0 (0%) 2 (5%) 2 (5%)\nWiemken 2013 Severe CAP admitted to ICU 468, 84% adults PS USA NAAT 106 (23%) Influenza 38 (8%) Rhinovirus 40 (9%) 0 (0%0 8 (2%) 15 (3%) 4 (1%) 1 (0.2%)\nKarhu 2014 Severe CAP 49 PS, BAL, TA Finland NAAT 24 (49%) 1 (2%) Rhinovirus 15 (30%)\nEnterovirus 2 (4%) 2 (4%) 1 (2%) 0 (0%) 1 (2%) 4 (8%)\nTramuto 2016 ILI admitted to ICU 233 PS, BAL Italy NAAT 102 (44%) 57 (24%) Rhinovirus 7 (3%)\nEnterovirus 14 (6%) 11 (5%) 8 (3%) 16 (7%) 16 (7%) 0 (0%)\nChoi 2019a Severe CAP admitted to ICU 1559 PS, BAL Republic of Korea NAAT Not reported 109 (7.0%) Rhinovirus 120 (8%) 56 (4%) 52 (3%) 50 (3%) 71 (5%) Not reported\nShorr 2018 Severe CAP and HCAP requiring IMV 364 sputum, TA, BAL USA NAAT 65 (18%) Influenza A 12 (3%)\nInfluenza B 1 (0.3%) Rhinovirus/Enterovirus 20 (5%) Not reported 11 (3%) 8 (2%) 7 (2%) 6 (2%)\nLegoff 2018 Hematology patients admitted to ICU 747 PS France NAAT 163 (22%) 20 (3%) 92 (12%) 22 (3%) 18 (2%) 4 (0.5%), 12 (2%) 5 (0.6%)\nVoiriot 2016 Severe CAP admitted to ICU 174 PS, TA, BAL France NAAT 93 (53%) Influenza A 32 (18%) Influenza B 6 (3%) Rhinovirus/Enterovirus 22 (13%) 14 (8%) 9 (5%) 12 (7%) 3 (2%) 3 (2%)\nArabi 2018 Severe acute respiratory infection admitted to ICU 222 PS, TA, BAL Saudi Arabia NAAT 43 (19%) Influenza A 29 (13%) Influenza B 3 (1%) Rhinovirus 9 (4%)\nEnterovirus 0 (0%) 5 (2%) 1 (0.5%) 1 (0.5%) 1 (0.5%) 1 (0.5%)"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T2","span":{"begin":1689,"end":1695},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma312401"}],"text":"Study Population Patients (N) Samples Country Assays Overall prevalence or RVI Influenza Picornaviruses (rhinovirus, enterovirus) Human coronaviruses (229E, NL63, OC43, HKU1) Respiratory syncytial virus Human metapneumovirus Parainfluenza virus Adenovirus\nDaubin 2006 IMV for \u003e 48 h 187 TA France Viral culture, IFA, NAAT 32 (17%) Influenza A 7 (4%) Rhinovirus 19 (10%)\nEnterovirus 2 (1%) 1 (0.5%) 2 (1%) 0 (0%) 1 (0.5%) 1 (0.5%)\nCameron 2006 COPD exacerbation requiring NIV or IMV 105 PS Australia IFA, viral culture, NAAT, serology 46 (43%) Influenza A 14 (13%)\nInfluenza B 6 (6%) Rhinovirus 7 (7%)\nEnterovirus 2 (2%) 3 (3%) 7 (7%) 3 (3%) 11 (10%) 0 (0%)\nSchnell 2014 Acute respiratory failure 70, 47 (67%) mechanically ventilated PS, BAL France IFA, NAAT 34 (49%) Influenza A 11 (16%)\nInfluenza B 2 (3%) Rhinovirus 6 (9%) 5 (7%) 4 (6%) 4 (6%) 1 (1%) 3 (4%)\nLegoff 2005 Acute pneumonia admitted to ICU 41 BAL France Viral culture, IFA, NAAT 13 (32%) Influenza A 7 (17%)\nInfluenza B 1 (2%) 0 (0%) 0 (0%) 2 (5%) 0 (0%) 2 (5%) 2 (5%)\nWiemken 2013 Severe CAP admitted to ICU 468, 84% adults PS USA NAAT 106 (23%) Influenza 38 (8%) Rhinovirus 40 (9%) 0 (0%0 8 (2%) 15 (3%) 4 (1%) 1 (0.2%)\nKarhu 2014 Severe CAP 49 PS, BAL, TA Finland NAAT 24 (49%) 1 (2%) Rhinovirus 15 (30%)\nEnterovirus 2 (4%) 2 (4%) 1 (2%) 0 (0%) 1 (2%) 4 (8%)\nTramuto 2016 ILI admitted to ICU 233 PS, BAL Italy NAAT 102 (44%) 57 (24%) Rhinovirus 7 (3%)\nEnterovirus 14 (6%) 11 (5%) 8 (3%) 16 (7%) 16 (7%) 0 (0%)\nChoi 2019a Severe CAP admitted to ICU 1559 PS, BAL Republic of Korea NAAT Not reported 109 (7.0%) Rhinovirus 120 (8%) 56 (4%) 52 (3%) 50 (3%) 71 (5%) Not reported\nShorr 2018 Severe CAP and HCAP requiring IMV 364 sputum, TA, BAL USA NAAT 65 (18%) Influenza A 12 (3%)\nInfluenza B 1 (0.3%) Rhinovirus/Enterovirus 20 (5%) Not reported 11 (3%) 8 (2%) 7 (2%) 6 (2%)\nLegoff 2018 Hematology patients admitted to ICU 747 PS France NAAT 163 (22%) 20 (3%) 92 (12%) 22 (3%) 18 (2%) 4 (0.5%), 12 (2%) 5 (0.6%)\nVoiriot 2016 Severe CAP admitted to ICU 174 PS, TA, BAL France NAAT 93 (53%) Influenza A 32 (18%) Influenza B 6 (3%) Rhinovirus/Enterovirus 22 (13%) 14 (8%) 9 (5%) 12 (7%) 3 (2%) 3 (2%)\nArabi 2018 Severe acute respiratory infection admitted to ICU 222 PS, TA, BAL Saudi Arabia NAAT 43 (19%) Influenza A 29 (13%) Influenza B 3 (1%) Rhinovirus 9 (4%)\nEnterovirus 0 (0%) 5 (2%) 1 (0.5%) 1 (0.5%) 1 (0.5%) 1 (0.5%)"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":1689,"end":1695},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0007311"}],"text":"Study Population Patients (N) Samples Country Assays Overall prevalence or RVI Influenza Picornaviruses (rhinovirus, enterovirus) Human coronaviruses (229E, NL63, OC43, HKU1) Respiratory syncytial virus Human metapneumovirus Parainfluenza virus Adenovirus\nDaubin 2006 IMV for \u003e 48 h 187 TA France Viral culture, IFA, NAAT 32 (17%) Influenza A 7 (4%) Rhinovirus 19 (10%)\nEnterovirus 2 (1%) 1 (0.5%) 2 (1%) 0 (0%) 1 (0.5%) 1 (0.5%)\nCameron 2006 COPD exacerbation requiring NIV or IMV 105 PS Australia IFA, viral culture, NAAT, serology 46 (43%) Influenza A 14 (13%)\nInfluenza B 6 (6%) Rhinovirus 7 (7%)\nEnterovirus 2 (2%) 3 (3%) 7 (7%) 3 (3%) 11 (10%) 0 (0%)\nSchnell 2014 Acute respiratory failure 70, 47 (67%) mechanically ventilated PS, BAL France IFA, NAAT 34 (49%) Influenza A 11 (16%)\nInfluenza B 2 (3%) Rhinovirus 6 (9%) 5 (7%) 4 (6%) 4 (6%) 1 (1%) 3 (4%)\nLegoff 2005 Acute pneumonia admitted to ICU 41 BAL France Viral culture, IFA, NAAT 13 (32%) Influenza A 7 (17%)\nInfluenza B 1 (2%) 0 (0%) 0 (0%) 2 (5%) 0 (0%) 2 (5%) 2 (5%)\nWiemken 2013 Severe CAP admitted to ICU 468, 84% adults PS USA NAAT 106 (23%) Influenza 38 (8%) Rhinovirus 40 (9%) 0 (0%0 8 (2%) 15 (3%) 4 (1%) 1 (0.2%)\nKarhu 2014 Severe CAP 49 PS, BAL, TA Finland NAAT 24 (49%) 1 (2%) Rhinovirus 15 (30%)\nEnterovirus 2 (4%) 2 (4%) 1 (2%) 0 (0%) 1 (2%) 4 (8%)\nTramuto 2016 ILI admitted to ICU 233 PS, BAL Italy NAAT 102 (44%) 57 (24%) Rhinovirus 7 (3%)\nEnterovirus 14 (6%) 11 (5%) 8 (3%) 16 (7%) 16 (7%) 0 (0%)\nChoi 2019a Severe CAP admitted to ICU 1559 PS, BAL Republic of Korea NAAT Not reported 109 (7.0%) Rhinovirus 120 (8%) 56 (4%) 52 (3%) 50 (3%) 71 (5%) Not reported\nShorr 2018 Severe CAP and HCAP requiring IMV 364 sputum, TA, BAL USA NAAT 65 (18%) Influenza A 12 (3%)\nInfluenza B 1 (0.3%) Rhinovirus/Enterovirus 20 (5%) Not reported 11 (3%) 8 (2%) 7 (2%) 6 (2%)\nLegoff 2018 Hematology patients admitted to ICU 747 PS France NAAT 163 (22%) 20 (3%) 92 (12%) 22 (3%) 18 (2%) 4 (0.5%), 12 (2%) 5 (0.6%)\nVoiriot 2016 Severe CAP admitted to ICU 174 PS, TA, BAL France NAAT 93 (53%) Influenza A 32 (18%) Influenza B 6 (3%) Rhinovirus/Enterovirus 22 (13%) 14 (8%) 9 (5%) 12 (7%) 3 (2%) 3 (2%)\nArabi 2018 Severe acute respiratory infection admitted to ICU 222 PS, TA, BAL Saudi Arabia NAAT 43 (19%) Influenza A 29 (13%) Influenza B 3 (1%) Rhinovirus 9 (4%)\nEnterovirus 0 (0%) 5 (2%) 1 (0.5%) 1 (0.5%) 1 (0.5%) 1 (0.5%)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T22","span":{"begin":79,"end":88},"obj":"Disease"},{"id":"T23","span":{"begin":287,"end":289},"obj":"Disease"},{"id":"T24","span":{"begin":331,"end":340},"obj":"Disease"},{"id":"T25","span":{"begin":443,"end":447},"obj":"Disease"},{"id":"T26","span":{"begin":543,"end":552},"obj":"Disease"},{"id":"T27","span":{"begin":564,"end":573},"obj":"Disease"},{"id":"T28","span":{"begin":670,"end":695},"obj":"Disease"},{"id":"T29","span":{"begin":676,"end":695},"obj":"Disease"},{"id":"T30","span":{"begin":767,"end":776},"obj":"Disease"},{"id":"T31","span":{"begin":788,"end":797},"obj":"Disease"},{"id":"T32","span":{"begin":878,"end":887},"obj":"Disease"},{"id":"T33","span":{"begin":952,"end":961},"obj":"Disease"},{"id":"T34","span":{"begin":972,"end":981},"obj":"Disease"},{"id":"T35","span":{"begin":1111,"end":1120},"obj":"Disease"},{"id":"T36","span":{"begin":1220,"end":1222},"obj":"Disease"},{"id":"T37","span":{"begin":1697,"end":1699},"obj":"Disease"},{"id":"T38","span":{"begin":1723,"end":1732},"obj":"Disease"},{"id":"T39","span":{"begin":1743,"end":1752},"obj":"Disease"},{"id":"T40","span":{"begin":2022,"end":2024},"obj":"Disease"},{"id":"T41","span":{"begin":2051,"end":2060},"obj":"Disease"},{"id":"T42","span":{"begin":2072,"end":2081},"obj":"Disease"},{"id":"T43","span":{"begin":2184,"end":2205},"obj":"Disease"},{"id":"T44","span":{"begin":2196,"end":2205},"obj":"Disease"},{"id":"T45","span":{"begin":2230,"end":2232},"obj":"Disease"},{"id":"T46","span":{"begin":2265,"end":2274},"obj":"Disease"},{"id":"T47","span":{"begin":2286,"end":2295},"obj":"Disease"}],"attributes":[{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0017991"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0005002"},{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A27","pred":"mondo_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A28","pred":"mondo_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/MONDO_0001208"},{"id":"A29","pred":"mondo_id","subj":"T29","obj":"http://purl.obolibrary.org/obo/MONDO_0021113"},{"id":"A30","pred":"mondo_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A31","pred":"mondo_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A35","pred":"mondo_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0017991"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0017991"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0017991"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A42","pred":"mondo_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A43","pred":"mondo_id","subj":"T43","obj":"http://purl.obolibrary.org/obo/MONDO_0024355"},{"id":"A44","pred":"mondo_id","subj":"T44","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0017991"},{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"Study Population Patients (N) Samples Country Assays Overall prevalence or RVI Influenza Picornaviruses (rhinovirus, enterovirus) Human coronaviruses (229E, NL63, OC43, HKU1) Respiratory syncytial virus Human metapneumovirus Parainfluenza virus Adenovirus\nDaubin 2006 IMV for \u003e 48 h 187 TA France Viral culture, IFA, NAAT 32 (17%) Influenza A 7 (4%) Rhinovirus 19 (10%)\nEnterovirus 2 (1%) 1 (0.5%) 2 (1%) 0 (0%) 1 (0.5%) 1 (0.5%)\nCameron 2006 COPD exacerbation requiring NIV or IMV 105 PS Australia IFA, viral culture, NAAT, serology 46 (43%) Influenza A 14 (13%)\nInfluenza B 6 (6%) Rhinovirus 7 (7%)\nEnterovirus 2 (2%) 3 (3%) 7 (7%) 3 (3%) 11 (10%) 0 (0%)\nSchnell 2014 Acute respiratory failure 70, 47 (67%) mechanically ventilated PS, BAL France IFA, NAAT 34 (49%) Influenza A 11 (16%)\nInfluenza B 2 (3%) Rhinovirus 6 (9%) 5 (7%) 4 (6%) 4 (6%) 1 (1%) 3 (4%)\nLegoff 2005 Acute pneumonia admitted to ICU 41 BAL France Viral culture, IFA, NAAT 13 (32%) Influenza A 7 (17%)\nInfluenza B 1 (2%) 0 (0%) 0 (0%) 2 (5%) 0 (0%) 2 (5%) 2 (5%)\nWiemken 2013 Severe CAP admitted to ICU 468, 84% adults PS USA NAAT 106 (23%) Influenza 38 (8%) Rhinovirus 40 (9%) 0 (0%0 8 (2%) 15 (3%) 4 (1%) 1 (0.2%)\nKarhu 2014 Severe CAP 49 PS, BAL, TA Finland NAAT 24 (49%) 1 (2%) Rhinovirus 15 (30%)\nEnterovirus 2 (4%) 2 (4%) 1 (2%) 0 (0%) 1 (2%) 4 (8%)\nTramuto 2016 ILI admitted to ICU 233 PS, BAL Italy NAAT 102 (44%) 57 (24%) Rhinovirus 7 (3%)\nEnterovirus 14 (6%) 11 (5%) 8 (3%) 16 (7%) 16 (7%) 0 (0%)\nChoi 2019a Severe CAP admitted to ICU 1559 PS, BAL Republic of Korea NAAT Not reported 109 (7.0%) Rhinovirus 120 (8%) 56 (4%) 52 (3%) 50 (3%) 71 (5%) Not reported\nShorr 2018 Severe CAP and HCAP requiring IMV 364 sputum, TA, BAL USA NAAT 65 (18%) Influenza A 12 (3%)\nInfluenza B 1 (0.3%) Rhinovirus/Enterovirus 20 (5%) Not reported 11 (3%) 8 (2%) 7 (2%) 6 (2%)\nLegoff 2018 Hematology patients admitted to ICU 747 PS France NAAT 163 (22%) 20 (3%) 92 (12%) 22 (3%) 18 (2%) 4 (0.5%), 12 (2%) 5 (0.6%)\nVoiriot 2016 Severe CAP admitted to ICU 174 PS, TA, BAL France NAAT 93 (53%) Influenza A 32 (18%) Influenza B 6 (3%) Rhinovirus/Enterovirus 22 (13%) 14 (8%) 9 (5%) 12 (7%) 3 (2%) 3 (2%)\nArabi 2018 Severe acute respiratory infection admitted to ICU 222 PS, TA, BAL Saudi Arabia NAAT 43 (19%) Influenza A 29 (13%) Influenza B 3 (1%) Rhinovirus 9 (4%)\nEnterovirus 0 (0%) 5 (2%) 1 (0.5%) 1 (0.5%) 1 (0.5%) 1 (0.5%)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17","span":{"begin":130,"end":135},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T18","span":{"begin":197,"end":202},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T19","span":{"begin":203,"end":208},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T20","span":{"begin":239,"end":244},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T21","span":{"begin":278,"end":280},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T22","span":{"begin":281,"end":286},"obj":"http://purl.obolibrary.org/obo/CLO_0003584"},{"id":"T23","span":{"begin":341,"end":344},"obj":"http://purl.obolibrary.org/obo/CLO_0001608"},{"id":"T24","span":{"begin":384,"end":390},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T25","span":{"begin":486,"end":488},"obj":"http://purl.obolibrary.org/obo/CLO_0008491"},{"id":"T26","span":{"begin":553,"end":554},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T27","span":{"begin":574,"end":575},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T28","span":{"begin":636,"end":643},"obj":"http://purl.obolibrary.org/obo/CLO_0001006"},{"id":"T29","span":{"begin":733,"end":735},"obj":"http://purl.obolibrary.org/obo/CLO_0008491"},{"id":"T30","span":{"begin":758,"end":760},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T31","span":{"begin":777,"end":781},"obj":"http://purl.obolibrary.org/obo/CLO_0001553"},{"id":"T32","span":{"begin":798,"end":799},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T33","span":{"begin":832,"end":840},"obj":"http://purl.obolibrary.org/obo/CLO_0001376"},{"id":"T34","span":{"begin":832,"end":840},"obj":"http://purl.obolibrary.org/obo/CLO_0001378"},{"id":"T35","span":{"begin":904,"end":906},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T36","span":{"begin":962,"end":965},"obj":"http://purl.obolibrary.org/obo/CLO_0001608"},{"id":"T37","span":{"begin":982,"end":983},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T38","span":{"begin":1021,"end":1027},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T39","span":{"begin":1089,"end":1091},"obj":"http://purl.obolibrary.org/obo/CLO_0008491"},{"id":"T40","span":{"begin":1165,"end":1171},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T41","span":{"begin":1172,"end":1178},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T42","span":{"begin":1211,"end":1213},"obj":"http://purl.obolibrary.org/obo/CLO_0008491"},{"id":"T43","span":{"begin":1239,"end":1246},"obj":"http://purl.obolibrary.org/obo/CLO_0054064"},{"id":"T44","span":{"begin":1293,"end":1299},"obj":"http://purl.obolibrary.org/obo/CLO_0053794"},{"id":"T45","span":{"begin":1363,"end":1365},"obj":"http://purl.obolibrary.org/obo/CLO_0008491"},{"id":"T46","span":{"begin":1382,"end":1385},"obj":"http://purl.obolibrary.org/obo/CLO_0054060"},{"id":"T47","span":{"begin":1439,"end":1441},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T48","span":{"begin":1520,"end":1522},"obj":"http://purl.obolibrary.org/obo/CLO_0008491"},{"id":"T49","span":{"begin":1603,"end":1605},"obj":"http://purl.obolibrary.org/obo/CLO_0001407"},{"id":"T50","span":{"begin":1619,"end":1621},"obj":"http://purl.obolibrary.org/obo/CLO_0054055"},{"id":"T51","span":{"begin":1646,"end":1650},"obj":"http://purl.obolibrary.org/obo/CLO_0001185"},{"id":"T52","span":{"begin":1718,"end":1720},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T53","span":{"begin":1733,"end":1734},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T54","span":{"begin":1753,"end":1754},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T55","span":{"begin":1808,"end":1810},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T56","span":{"begin":1818,"end":1824},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T57","span":{"begin":1844,"end":1848},"obj":"http://purl.obolibrary.org/obo/CLO_0001185"},{"id":"T58","span":{"begin":1889,"end":1891},"obj":"http://purl.obolibrary.org/obo/CLO_0008491"},{"id":"T59","span":{"begin":1904,"end":1907},"obj":"http://purl.obolibrary.org/obo/CLO_0001003"},{"id":"T60","span":{"begin":1909,"end":1911},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T61","span":{"begin":1931,"end":1933},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T62","span":{"begin":1939,"end":1941},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T63","span":{"begin":2018,"end":2020},"obj":"http://purl.obolibrary.org/obo/CLO_0008491"},{"id":"T64","span":{"begin":2061,"end":2062},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T65","span":{"begin":2067,"end":2069},"obj":"http://purl.obolibrary.org/obo/CLO_0050510"},{"id":"T66","span":{"begin":2082,"end":2083},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T67","span":{"begin":2114,"end":2116},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T68","span":{"begin":2166,"end":2170},"obj":"http://purl.obolibrary.org/obo/CLO_0001185"},{"id":"T69","span":{"begin":2226,"end":2228},"obj":"http://purl.obolibrary.org/obo/CLO_0008491"},{"id":"T70","span":{"begin":2275,"end":2276},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T71","span":{"begin":2296,"end":2299},"obj":"http://purl.obolibrary.org/obo/CLO_0001812"}],"text":"Study Population Patients (N) Samples Country Assays Overall prevalence or RVI Influenza Picornaviruses (rhinovirus, enterovirus) Human coronaviruses (229E, NL63, OC43, HKU1) Respiratory syncytial virus Human metapneumovirus Parainfluenza virus Adenovirus\nDaubin 2006 IMV for \u003e 48 h 187 TA France Viral culture, IFA, NAAT 32 (17%) Influenza A 7 (4%) Rhinovirus 19 (10%)\nEnterovirus 2 (1%) 1 (0.5%) 2 (1%) 0 (0%) 1 (0.5%) 1 (0.5%)\nCameron 2006 COPD exacerbation requiring NIV or IMV 105 PS Australia IFA, viral culture, NAAT, serology 46 (43%) Influenza A 14 (13%)\nInfluenza B 6 (6%) Rhinovirus 7 (7%)\nEnterovirus 2 (2%) 3 (3%) 7 (7%) 3 (3%) 11 (10%) 0 (0%)\nSchnell 2014 Acute respiratory failure 70, 47 (67%) mechanically ventilated PS, BAL France IFA, NAAT 34 (49%) Influenza A 11 (16%)\nInfluenza B 2 (3%) Rhinovirus 6 (9%) 5 (7%) 4 (6%) 4 (6%) 1 (1%) 3 (4%)\nLegoff 2005 Acute pneumonia admitted to ICU 41 BAL France Viral culture, IFA, NAAT 13 (32%) Influenza A 7 (17%)\nInfluenza B 1 (2%) 0 (0%) 0 (0%) 2 (5%) 0 (0%) 2 (5%) 2 (5%)\nWiemken 2013 Severe CAP admitted to ICU 468, 84% adults PS USA NAAT 106 (23%) Influenza 38 (8%) Rhinovirus 40 (9%) 0 (0%0 8 (2%) 15 (3%) 4 (1%) 1 (0.2%)\nKarhu 2014 Severe CAP 49 PS, BAL, TA Finland NAAT 24 (49%) 1 (2%) Rhinovirus 15 (30%)\nEnterovirus 2 (4%) 2 (4%) 1 (2%) 0 (0%) 1 (2%) 4 (8%)\nTramuto 2016 ILI admitted to ICU 233 PS, BAL Italy NAAT 102 (44%) 57 (24%) Rhinovirus 7 (3%)\nEnterovirus 14 (6%) 11 (5%) 8 (3%) 16 (7%) 16 (7%) 0 (0%)\nChoi 2019a Severe CAP admitted to ICU 1559 PS, BAL Republic of Korea NAAT Not reported 109 (7.0%) Rhinovirus 120 (8%) 56 (4%) 52 (3%) 50 (3%) 71 (5%) Not reported\nShorr 2018 Severe CAP and HCAP requiring IMV 364 sputum, TA, BAL USA NAAT 65 (18%) Influenza A 12 (3%)\nInfluenza B 1 (0.3%) Rhinovirus/Enterovirus 20 (5%) Not reported 11 (3%) 8 (2%) 7 (2%) 6 (2%)\nLegoff 2018 Hematology patients admitted to ICU 747 PS France NAAT 163 (22%) 20 (3%) 92 (12%) 22 (3%) 18 (2%) 4 (0.5%), 12 (2%) 5 (0.6%)\nVoiriot 2016 Severe CAP admitted to ICU 174 PS, TA, BAL France NAAT 93 (53%) Influenza A 32 (18%) Influenza B 6 (3%) Rhinovirus/Enterovirus 22 (13%) 14 (8%) 9 (5%) 12 (7%) 3 (2%) 3 (2%)\nArabi 2018 Severe acute respiratory infection admitted to ICU 222 PS, TA, BAL Saudi Arabia NAAT 43 (19%) Influenza A 29 (13%) Influenza B 3 (1%) Rhinovirus 9 (4%)\nEnterovirus 0 (0%) 5 (2%) 1 (0.5%) 1 (0.5%) 1 (0.5%) 1 (0.5%)"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T15","span":{"begin":287,"end":289},"obj":"Chemical"},{"id":"T16","span":{"begin":486,"end":488},"obj":"Chemical"},{"id":"T19","span":{"begin":733,"end":735},"obj":"Chemical"},{"id":"T22","span":{"begin":737,"end":740},"obj":"Chemical"},{"id":"T23","span":{"begin":907,"end":910},"obj":"Chemical"},{"id":"T24","span":{"begin":1089,"end":1091},"obj":"Chemical"},{"id":"T27","span":{"begin":1211,"end":1213},"obj":"Chemical"},{"id":"T30","span":{"begin":1215,"end":1218},"obj":"Chemical"},{"id":"T31","span":{"begin":1220,"end":1222},"obj":"Chemical"},{"id":"T32","span":{"begin":1363,"end":1365},"obj":"Chemical"},{"id":"T35","span":{"begin":1367,"end":1370},"obj":"Chemical"},{"id":"T36","span":{"begin":1520,"end":1522},"obj":"Chemical"},{"id":"T39","span":{"begin":1524,"end":1527},"obj":"Chemical"},{"id":"T40","span":{"begin":1697,"end":1699},"obj":"Chemical"},{"id":"T41","span":{"begin":1701,"end":1704},"obj":"Chemical"},{"id":"T42","span":{"begin":1889,"end":1891},"obj":"Chemical"},{"id":"T45","span":{"begin":2018,"end":2020},"obj":"Chemical"},{"id":"T48","span":{"begin":2022,"end":2024},"obj":"Chemical"},{"id":"T49","span":{"begin":2026,"end":2029},"obj":"Chemical"},{"id":"T50","span":{"begin":2226,"end":2228},"obj":"Chemical"},{"id":"T53","span":{"begin":2230,"end":2232},"obj":"Chemical"},{"id":"T54","span":{"begin":2234,"end":2237},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"chebi_id","subj":"T15","obj":"http://purl.obolibrary.org/obo/CHEBI_74824"},{"id":"A16","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_18303"},{"id":"A17","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"},{"id":"A18","pred":"chebi_id","subj":"T16","obj":"http://purl.obolibrary.org/obo/CHEBI_73648"},{"id":"A19","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_18303"},{"id":"A20","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"},{"id":"A21","pred":"chebi_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/CHEBI_73648"},{"id":"A22","pred":"chebi_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A23","pred":"chebi_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A24","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_18303"},{"id":"A25","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"},{"id":"A26","pred":"chebi_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/CHEBI_73648"},{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_18303"},{"id":"A28","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"},{"id":"A29","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_73648"},{"id":"A30","pred":"chebi_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_74824"},{"id":"A32","pred":"chebi_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/CHEBI_18303"},{"id":"A33","pred":"chebi_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"},{"id":"A34","pred":"chebi_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/CHEBI_73648"},{"id":"A35","pred":"chebi_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A36","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_18303"},{"id":"A37","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"},{"id":"A38","pred":"chebi_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/CHEBI_73648"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_74824"},{"id":"A41","pred":"chebi_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A42","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_18303"},{"id":"A43","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"},{"id":"A44","pred":"chebi_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/CHEBI_73648"},{"id":"A45","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_18303"},{"id":"A46","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"},{"id":"A47","pred":"chebi_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/CHEBI_73648"},{"id":"A48","pred":"chebi_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/CHEBI_74824"},{"id":"A49","pred":"chebi_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A50","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_18303"},{"id":"A51","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_53276"},{"id":"A52","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_73648"},{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_74824"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"}],"text":"Study Population Patients (N) Samples Country Assays Overall prevalence or RVI Influenza Picornaviruses (rhinovirus, enterovirus) Human coronaviruses (229E, NL63, OC43, HKU1) Respiratory syncytial virus Human metapneumovirus Parainfluenza virus Adenovirus\nDaubin 2006 IMV for \u003e 48 h 187 TA France Viral culture, IFA, NAAT 32 (17%) Influenza A 7 (4%) Rhinovirus 19 (10%)\nEnterovirus 2 (1%) 1 (0.5%) 2 (1%) 0 (0%) 1 (0.5%) 1 (0.5%)\nCameron 2006 COPD exacerbation requiring NIV or IMV 105 PS Australia IFA, viral culture, NAAT, serology 46 (43%) Influenza A 14 (13%)\nInfluenza B 6 (6%) Rhinovirus 7 (7%)\nEnterovirus 2 (2%) 3 (3%) 7 (7%) 3 (3%) 11 (10%) 0 (0%)\nSchnell 2014 Acute respiratory failure 70, 47 (67%) mechanically ventilated PS, BAL France IFA, NAAT 34 (49%) Influenza A 11 (16%)\nInfluenza B 2 (3%) Rhinovirus 6 (9%) 5 (7%) 4 (6%) 4 (6%) 1 (1%) 3 (4%)\nLegoff 2005 Acute pneumonia admitted to ICU 41 BAL France Viral culture, IFA, NAAT 13 (32%) Influenza A 7 (17%)\nInfluenza B 1 (2%) 0 (0%) 0 (0%) 2 (5%) 0 (0%) 2 (5%) 2 (5%)\nWiemken 2013 Severe CAP admitted to ICU 468, 84% adults PS USA NAAT 106 (23%) Influenza 38 (8%) Rhinovirus 40 (9%) 0 (0%0 8 (2%) 15 (3%) 4 (1%) 1 (0.2%)\nKarhu 2014 Severe CAP 49 PS, BAL, TA Finland NAAT 24 (49%) 1 (2%) Rhinovirus 15 (30%)\nEnterovirus 2 (4%) 2 (4%) 1 (2%) 0 (0%) 1 (2%) 4 (8%)\nTramuto 2016 ILI admitted to ICU 233 PS, BAL Italy NAAT 102 (44%) 57 (24%) Rhinovirus 7 (3%)\nEnterovirus 14 (6%) 11 (5%) 8 (3%) 16 (7%) 16 (7%) 0 (0%)\nChoi 2019a Severe CAP admitted to ICU 1559 PS, BAL Republic of Korea NAAT Not reported 109 (7.0%) Rhinovirus 120 (8%) 56 (4%) 52 (3%) 50 (3%) 71 (5%) Not reported\nShorr 2018 Severe CAP and HCAP requiring IMV 364 sputum, TA, BAL USA NAAT 65 (18%) Influenza A 12 (3%)\nInfluenza B 1 (0.3%) Rhinovirus/Enterovirus 20 (5%) Not reported 11 (3%) 8 (2%) 7 (2%) 6 (2%)\nLegoff 2018 Hematology patients admitted to ICU 747 PS France NAAT 163 (22%) 20 (3%) 92 (12%) 22 (3%) 18 (2%) 4 (0.5%), 12 (2%) 5 (0.6%)\nVoiriot 2016 Severe CAP admitted to ICU 174 PS, TA, BAL France NAAT 93 (53%) Influenza A 32 (18%) Influenza B 6 (3%) Rhinovirus/Enterovirus 22 (13%) 14 (8%) 9 (5%) 12 (7%) 3 (2%) 3 (2%)\nArabi 2018 Severe acute respiratory infection admitted to ICU 222 PS, TA, BAL Saudi Arabia NAAT 43 (19%) Influenza A 29 (13%) Influenza B 3 (1%) Rhinovirus 9 (4%)\nEnterovirus 0 (0%) 5 (2%) 1 (0.5%) 1 (0.5%) 1 (0.5%) 1 (0.5%)"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T6","span":{"begin":443,"end":447},"obj":"Phenotype"},{"id":"T7","span":{"begin":676,"end":695},"obj":"Phenotype"},{"id":"T8","span":{"begin":878,"end":887},"obj":"Phenotype"},{"id":"T9","span":{"begin":2184,"end":2205},"obj":"Phenotype"}],"attributes":[{"id":"A6","pred":"hp_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0002878"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A9","pred":"hp_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/HP_0011947"}],"text":"Study Population Patients (N) Samples Country Assays Overall prevalence or RVI Influenza Picornaviruses (rhinovirus, enterovirus) Human coronaviruses (229E, NL63, OC43, HKU1) Respiratory syncytial virus Human metapneumovirus Parainfluenza virus Adenovirus\nDaubin 2006 IMV for \u003e 48 h 187 TA France Viral culture, IFA, NAAT 32 (17%) Influenza A 7 (4%) Rhinovirus 19 (10%)\nEnterovirus 2 (1%) 1 (0.5%) 2 (1%) 0 (0%) 1 (0.5%) 1 (0.5%)\nCameron 2006 COPD exacerbation requiring NIV or IMV 105 PS Australia IFA, viral culture, NAAT, serology 46 (43%) Influenza A 14 (13%)\nInfluenza B 6 (6%) Rhinovirus 7 (7%)\nEnterovirus 2 (2%) 3 (3%) 7 (7%) 3 (3%) 11 (10%) 0 (0%)\nSchnell 2014 Acute respiratory failure 70, 47 (67%) mechanically ventilated PS, BAL France IFA, NAAT 34 (49%) Influenza A 11 (16%)\nInfluenza B 2 (3%) Rhinovirus 6 (9%) 5 (7%) 4 (6%) 4 (6%) 1 (1%) 3 (4%)\nLegoff 2005 Acute pneumonia admitted to ICU 41 BAL France Viral culture, IFA, NAAT 13 (32%) Influenza A 7 (17%)\nInfluenza B 1 (2%) 0 (0%) 0 (0%) 2 (5%) 0 (0%) 2 (5%) 2 (5%)\nWiemken 2013 Severe CAP admitted to ICU 468, 84% adults PS USA NAAT 106 (23%) Influenza 38 (8%) Rhinovirus 40 (9%) 0 (0%0 8 (2%) 15 (3%) 4 (1%) 1 (0.2%)\nKarhu 2014 Severe CAP 49 PS, BAL, TA Finland NAAT 24 (49%) 1 (2%) Rhinovirus 15 (30%)\nEnterovirus 2 (4%) 2 (4%) 1 (2%) 0 (0%) 1 (2%) 4 (8%)\nTramuto 2016 ILI admitted to ICU 233 PS, BAL Italy NAAT 102 (44%) 57 (24%) Rhinovirus 7 (3%)\nEnterovirus 14 (6%) 11 (5%) 8 (3%) 16 (7%) 16 (7%) 0 (0%)\nChoi 2019a Severe CAP admitted to ICU 1559 PS, BAL Republic of Korea NAAT Not reported 109 (7.0%) Rhinovirus 120 (8%) 56 (4%) 52 (3%) 50 (3%) 71 (5%) Not reported\nShorr 2018 Severe CAP and HCAP requiring IMV 364 sputum, TA, BAL USA NAAT 65 (18%) Influenza A 12 (3%)\nInfluenza B 1 (0.3%) Rhinovirus/Enterovirus 20 (5%) Not reported 11 (3%) 8 (2%) 7 (2%) 6 (2%)\nLegoff 2018 Hematology patients admitted to ICU 747 PS France NAAT 163 (22%) 20 (3%) 92 (12%) 22 (3%) 18 (2%) 4 (0.5%), 12 (2%) 5 (0.6%)\nVoiriot 2016 Severe CAP admitted to ICU 174 PS, TA, BAL France NAAT 93 (53%) Influenza A 32 (18%) Influenza B 6 (3%) Rhinovirus/Enterovirus 22 (13%) 14 (8%) 9 (5%) 12 (7%) 3 (2%) 3 (2%)\nArabi 2018 Severe acute respiratory infection admitted to ICU 222 PS, TA, BAL Saudi Arabia NAAT 43 (19%) Influenza A 29 (13%) Influenza B 3 (1%) Rhinovirus 9 (4%)\nEnterovirus 0 (0%) 5 (2%) 1 (0.5%) 1 (0.5%) 1 (0.5%) 1 (0.5%)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T24","span":{"begin":0,"end":255},"obj":"Sentence"},{"id":"T25","span":{"begin":256,"end":369},"obj":"Sentence"},{"id":"T26","span":{"begin":370,"end":429},"obj":"Sentence"},{"id":"T27","span":{"begin":430,"end":563},"obj":"Sentence"},{"id":"T28","span":{"begin":564,"end":600},"obj":"Sentence"},{"id":"T29","span":{"begin":601,"end":656},"obj":"Sentence"},{"id":"T30","span":{"begin":657,"end":787},"obj":"Sentence"},{"id":"T31","span":{"begin":788,"end":859},"obj":"Sentence"},{"id":"T32","span":{"begin":860,"end":971},"obj":"Sentence"},{"id":"T33","span":{"begin":972,"end":1032},"obj":"Sentence"},{"id":"T34","span":{"begin":1033,"end":1185},"obj":"Sentence"},{"id":"T35","span":{"begin":1186,"end":1271},"obj":"Sentence"},{"id":"T36","span":{"begin":1272,"end":1325},"obj":"Sentence"},{"id":"T37","span":{"begin":1326,"end":1418},"obj":"Sentence"},{"id":"T38","span":{"begin":1419,"end":1476},"obj":"Sentence"},{"id":"T39","span":{"begin":1477,"end":1639},"obj":"Sentence"},{"id":"T40","span":{"begin":1640,"end":1742},"obj":"Sentence"},{"id":"T41","span":{"begin":1743,"end":1836},"obj":"Sentence"},{"id":"T42","span":{"begin":1837,"end":1973},"obj":"Sentence"},{"id":"T43","span":{"begin":1974,"end":2159},"obj":"Sentence"},{"id":"T44","span":{"begin":2160,"end":2322},"obj":"Sentence"},{"id":"T45","span":{"begin":2323,"end":2384},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Study Population Patients (N) Samples Country Assays Overall prevalence or RVI Influenza Picornaviruses (rhinovirus, enterovirus) Human coronaviruses (229E, NL63, OC43, HKU1) Respiratory syncytial virus Human metapneumovirus Parainfluenza virus Adenovirus\nDaubin 2006 IMV for \u003e 48 h 187 TA France Viral culture, IFA, NAAT 32 (17%) Influenza A 7 (4%) Rhinovirus 19 (10%)\nEnterovirus 2 (1%) 1 (0.5%) 2 (1%) 0 (0%) 1 (0.5%) 1 (0.5%)\nCameron 2006 COPD exacerbation requiring NIV or IMV 105 PS Australia IFA, viral culture, NAAT, serology 46 (43%) Influenza A 14 (13%)\nInfluenza B 6 (6%) Rhinovirus 7 (7%)\nEnterovirus 2 (2%) 3 (3%) 7 (7%) 3 (3%) 11 (10%) 0 (0%)\nSchnell 2014 Acute respiratory failure 70, 47 (67%) mechanically ventilated PS, BAL France IFA, NAAT 34 (49%) Influenza A 11 (16%)\nInfluenza B 2 (3%) Rhinovirus 6 (9%) 5 (7%) 4 (6%) 4 (6%) 1 (1%) 3 (4%)\nLegoff 2005 Acute pneumonia admitted to ICU 41 BAL France Viral culture, IFA, NAAT 13 (32%) Influenza A 7 (17%)\nInfluenza B 1 (2%) 0 (0%) 0 (0%) 2 (5%) 0 (0%) 2 (5%) 2 (5%)\nWiemken 2013 Severe CAP admitted to ICU 468, 84% adults PS USA NAAT 106 (23%) Influenza 38 (8%) Rhinovirus 40 (9%) 0 (0%0 8 (2%) 15 (3%) 4 (1%) 1 (0.2%)\nKarhu 2014 Severe CAP 49 PS, BAL, TA Finland NAAT 24 (49%) 1 (2%) Rhinovirus 15 (30%)\nEnterovirus 2 (4%) 2 (4%) 1 (2%) 0 (0%) 1 (2%) 4 (8%)\nTramuto 2016 ILI admitted to ICU 233 PS, BAL Italy NAAT 102 (44%) 57 (24%) Rhinovirus 7 (3%)\nEnterovirus 14 (6%) 11 (5%) 8 (3%) 16 (7%) 16 (7%) 0 (0%)\nChoi 2019a Severe CAP admitted to ICU 1559 PS, BAL Republic of Korea NAAT Not reported 109 (7.0%) Rhinovirus 120 (8%) 56 (4%) 52 (3%) 50 (3%) 71 (5%) Not reported\nShorr 2018 Severe CAP and HCAP requiring IMV 364 sputum, TA, BAL USA NAAT 65 (18%) Influenza A 12 (3%)\nInfluenza B 1 (0.3%) Rhinovirus/Enterovirus 20 (5%) Not reported 11 (3%) 8 (2%) 7 (2%) 6 (2%)\nLegoff 2018 Hematology patients admitted to ICU 747 PS France NAAT 163 (22%) 20 (3%) 92 (12%) 22 (3%) 18 (2%) 4 (0.5%), 12 (2%) 5 (0.6%)\nVoiriot 2016 Severe CAP admitted to ICU 174 PS, TA, BAL France NAAT 93 (53%) Influenza A 32 (18%) Influenza B 6 (3%) Rhinovirus/Enterovirus 22 (13%) 14 (8%) 9 (5%) 12 (7%) 3 (2%) 3 (2%)\nArabi 2018 Severe acute respiratory infection admitted to ICU 222 PS, TA, BAL Saudi Arabia NAAT 43 (19%) Influenza A 29 (13%) Influenza B 3 (1%) Rhinovirus 9 (4%)\nEnterovirus 0 (0%) 5 (2%) 1 (0.5%) 1 (0.5%) 1 (0.5%) 1 (0.5%)"}